SELLAS LIFE SCIENCES GROUP I's ticker is SLS and the CUSIP is 81642T209. A total of 28 filers reported holding SELLAS LIFE SCIENCES GROUP I in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,969 | -70.0% | 2,420 | -71.3% | 0.00% | – |
| Q2 2023 | $13,219 | +71.2% | 8,420 | +55.9% | 0.00% | – |
| Q1 2023 | $7,722 | -94.1% | 5,400 | -90.3% | 0.00% | – |
| Q4 2022 | $131,117 | +21.4% | 55,558 | +4.0% | 0.00% | – |
| Q3 2022 | $108,000 | -47.1% | 53,425 | -41.6% | 0.00% | – |
| Q2 2022 | $204,000 | -66.6% | 91,471 | +0.2% | 0.00% | – |
| Q1 2022 | $610,000 | -11.1% | 91,299 | -26.5% | 0.00% | – |
| Q4 2021 | $686,000 | -59.5% | 124,134 | -32.9% | 0.00% | – |
| Q3 2021 | $1,694,000 | +884.9% | 184,868 | +1092.8% | 0.00% | – |
| Q2 2021 | $172,000 | +421.2% | 15,499 | +297.4% | 0.00% | – |
| Q1 2021 | $33,000 | +230.0% | 3,900 | +136.4% | 0.00% | – |
| Q4 2020 | $10,000 | +42.9% | 1,650 | -41.8% | 0.00% | – |
| Q3 2020 | $7,000 | -22.2% | 2,835 | -7.5% | 0.00% | – |
| Q2 2020 | $9,000 | -85.0% | 3,065 | -91.2% | 0.00% | – |
| Q1 2020 | $60,000 | +757.1% | 34,896 | +1940.7% | 0.00% | – |
| Q4 2019 | $7,000 | – | 1,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosperity Financial Group, Inc. | 24,800 | $40,672 | 0.03% |
| Alyeska Investment Group, L.P. | 1,000,000 | $1,640,000 | 0.01% |
| Opus Capital Group, LLC | 34,500 | $57 | 0.01% |
| XTX Topco Ltd | 32,982 | $54,090 | 0.01% |
| Alyeska Investment Group, L.P. | 640,011 | $1,049,618 | 0.01% |
| Virtu Financial LLC | 18,962 | $31 | 0.00% |
| Equitable Holdings, Inc. | 135,000 | $221,400 | 0.00% |
| Nemes Rush Group LLC | 10,000 | $16,400 | 0.00% |
| VANGUARD GROUP INC | 1,036,906 | $1,700,526 | 0.00% |
| JANE STREET GROUP, LLC | 11,032 | $18,092 | 0.00% |